Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism PARP-7 inhibitors(TCDD-inducible poly [ADP-ribose] polymerase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | - | 21 Oct 2022 |